Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC

NCT05343117 · clinicaltrials.gov ↗

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Hormone Receptor Positive Advanced Breast Cancer

Interventions

DRUG: Palbociclib based-therapy as initial endocrine therapy
DRUG: Palbociclib based-therapy after chemotherapy

Sponsor

Chinese Academy of Medical Sciences